Homeβ€ΊSearchβ€ΊOncologie

Oncologie

Walter de Gruyter GmbH Β· Germany Β· Est. 1985

ISSN1292-3818eISSN1765-2839
SJR Q3βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
90
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (2 more)+12
Total90
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
10
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q3
SJR Rank
Top 75% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.391
H-Indexi
20
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.429
Total Worksi
2,418
Total Citationsi
3,565
2yr Mean Citednessi
1.56
Open Impact Factor alternative

Aims & Scope

Oncologieis aimed at publishing high-quality original research articles and review papers with a focus on in vivo or in vitro studies of cancer biology and clinical research. It welcomes studies related to the pathology, prevention and diagnosis, and advanced treatment of all types of cancers, as well as research from any of the disciplines related to these fields of interest.The journal is owned byTech Science Press. Oncologieis an open access journal. It has French and English publications, currently publishes English-language articles mainly. The publication frequency is bimonthly.Aims & Scope Oncologiepublishes original research, reviews, case reports, and other contributions across all aspects of tumor and cancer research and treatment, including molecular and cellular oncology, cancer prevention, early detection and screening, diagnosis, and clinical management of neoplastic diseases. The journal welcomes both clinical and preclinical studies, including clinical trials, pharmacology, molecular alterations, and biomarkers predicting treatment response or resistance, as well asin vitroandin vivostudies of tumor biology, progression, metastasis, and therapy resistance. Research in precision oncology, personalized medicine, and molecular oncology is particularly encouraged, with an emphasis on translational research bridging laboratory discoveries with clinical applications. Methodological studies, including modern statistical approaches and meta-analyses Former publication ofOncologie(2004-2017):https://link.springer.com/journal/10269/volumes-and-issues(2018-2019):https://onco.revuesonline.com/component/issues(2019-2022):https://www.techscience.com/journal/oncologie

General Information

Country / RegionGermany
Primary LanguageFrench, English
1st Year Published1985
Frequencybimonthly
StatusActive (last: 2026)
Total Publications2,418
Publisher OrgSpringer Science+Business Media
OA Since2022
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~10 weeks
Acceptance Rateβ€”
OA LicenseCC BY
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
Portico

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Walter de Gruyter GmbH
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1292-3818 / 1765-2839
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
Portico
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
French, English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
14
5
2019
32
138
2020
47
238
2021
61
605
2022
88
321
2023
94
334
2024
98
61
2025
46
2
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

OncologyQ3

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Oncology

Research Topics (OpenAlex)

Health, Medicine and SocietyHealthcare Systems and PracticesCancer Treatment and PharmacologyBreast Cancer Treatment StudiesColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsMultiple and Secondary Primary CancersCancer Immunotherapy and BiomarkersSarcoma Diagnosis and TreatmentCancer survivorship and care

Frequently asked questions about Oncologie

Is Oncologie a predatory journal?

PubScope has no integrity flags on record for Oncologie: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Oncologie?

Oncologie is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.56.

Is Oncologie indexed in Scopus and Web of Science?

Oncologie is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Oncologie?

Oncologieis aimed at publishing high-quality original research articles and review papers with a focus on in vivo or in vitro studies of cancer biology and clinical research. It welcomes studies related to the pathology, prevention and diagnosis, and advanced treatment of all types of cancers, as well as research from any of the disciplines related to these fields of interest.The journal is owned byTech Science Press. Oncologieis an open access journal. It has French and English publications, currently publishes English-language articles mainly. The publication frequency is bimonthly.Aims & Sc

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref